Matthew Reilley, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seattle Genetics
    Topic:
    Advisor
    Date added:
    09/27/2023
    Date updated:
    09/27/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cicero
    Topic:
    Advisor
    Date added:
    09/27/2023
    Date updated:
    09/27/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cardinal Health
    Topic:
    Advisor
    Date added:
    09/27/2023
    Date updated:
    09/27/2023
Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond